147
Views
8
CrossRef citations to date
0
Altmetric
Original Research

First-Line Treatment with Tiotropium/Olodaterol Improves Physical Activity in Patients with Treatment-Naïve Chronic Obstructive Pulmonary Disease

ORCID Icon, ORCID Icon, , , , , , , , , , , , ORCID Icon, , , , ORCID Icon & show all
Pages 2115-2126 | Published online: 14 Sep 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Koichiro Takahashi, Hiroki Tashiro, Ryo Tajiri, Ayako Takamori, Masaru Uchida, Go Kato, Yuki Kurihara, Hironori Sadamatsu, Takashi Kinoshita, Makoto Yoshida, Atsushi Kawaguchi, Shinya Kimura, Naoko Sueoka-Aragane & Tomotaka Kawayama. (2021) Factors Associated with Reduction of Sedentary Time Following Tiotropium/Olodaterol Therapy in Treatment-Naïve Chronic Obstructive Pulmonary Disease. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 3297-3307.
Read now

Articles from other publishers (7)

Yoshiaki Minakata, Yuichiro Azuma, Seigo Sasaki & Yusuke Murakami. (2023) Objective Measurement of Physical Activity and Sedentary Behavior in Patients with Chronic Obstructive Pulmonary Disease: Points to Keep in Mind during Evaluations. Journal of Clinical Medicine 12:9, pages 3254.
Crossref
Yoriyuki Murata, Tsunahiko Hirano, Keiko Doi, Ayumi Fukatsu-Chikumoto, Kazuki Hamada, Keiji Oishi, Tomoyuki Kakugawa, Masafumi Yano & Kazuto Matsunaga. (2023) Computed Tomography Lung Density Analysis: An Imaging Biomarker Predicting Physical Inactivity in Chronic Obstructive Pulmonary Disease: A Pilot Study. Journal of Clinical Medicine 12:8, pages 2959.
Crossref
Hiroki Tashiro & Koichiro Takahashi. (2023) Clinical Impacts of Interventions for Physical Activity and Sedentary Behavior on Patients with Chronic Obstructive Pulmonary Disease. Journal of Clinical Medicine 12:4, pages 1631.
Crossref
Marc Miravitlles, Juan Luís García-Rivero, Xavier Ribera, Jordi Galera, Alejandra García, Rosa Palomino & Xavier Pomares. (2022) Exercise capacity and physical activity in COPD patients treated with a LAMA/LABA combination: a systematic review and meta-analysis. Respiratory Research 23:1.
Crossref
Marc Miravitlles, Tomotaka Kawayama & Michael Dreher. (2022) LABA/LAMA as First-Line Therapy for COPD: A Summary of the Evidence and Guideline Recommendations. Journal of Clinical Medicine 11:22, pages 6623.
Crossref
Atsuyasu Sato, Ai Miyazaki & Shuhei Nakamura. (2022) Effectiveness of Tiotropium/Olodaterol in the Real World: A Post Hoc Subgroup Analysis After the First Year of Use. Advances in Therapy 39:10, pages 4692-4706.
Crossref
Dave Singh, James F. Donohue, Isabelle H. Boucot, Neil C. Barnes, Chris Compton & Fernando J. Martinez. (2021) Future concepts in bronchodilation for COPD: dual- versus monotherapy . European Respiratory Review 30:160, pages 210023.
Crossref